Neoadjuvant Chemotherapy and Radiotherapy for the Treatment of Squamous Cell Carcinoma of the Tonsil.
- Author:
Byung Joo LEE
1
;
Hyun Sun LEE
;
Jun JEON
;
Young Il MOON
;
Eui Kyung GOH
;
Kyong Myong CHON
;
Dong Won KIM
;
Ji Ho NAM
;
Soo Geun WANG
Author Information
1. Department of Otolaryngology, College of Medicine, Busan National University, Busan, Korea. wangsg@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Tonsillar neoplasms;
Radiotherapy;
Neoadjuvant chemotherapy
- MeSH:
Busan;
Carcinoma, Squamous Cell*;
Drug Therapy*;
Humans;
Medical Records;
Palatine Tonsil*;
Prognosis;
Radiotherapy*;
Retrospective Studies;
Survival Rate;
Tonsillar Neoplasms
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2002;45(10):1004-1009
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Squamous cell carcinoma of the tonsil has a relatively poor prognosis. Surgery, radiation therapy and combinations of irradiation and surgery have been employed but there exists some controversy about the efficacy of these treatment modalities. The purpose of this study was to evaluate the efficacy of the neoadjuvant chemotherapy and radiotherapy in the treatment of tonsillar neoplasm. MATERIALS AND METHOD: Medical records of 21 patients who received neoadjuvant chemotherapy and radiotherapy for tonsillar neoplasm at Pusan National University Hospital from April 1995 through August 2000 were retrospectively reviewed. RESULTS: The three year survival rate was 81.0%. The three year survival rates for stages I,II were both 100%. For stages III, IV, the rates were 83.3%, 87.5%, respectively. The three year survival rate for T1, T2, T3 were 100%, 92.3%, 40.0%, respectively. CONCLUSION: Neoadjuvant chemotherapy and radiotherapy would be effective treatment modality for tonsillar neoplasm with high survival rate and low morbidity.
